Create an alert
to follow the executive moves at Boehringer Ingelheim.

Latest M&A news in Pharmaceuticals.

Purdue Pharma has filed for bankruptcy protection Purdue Pharma (posted on Sep 16, 2019).
Aytu BioScience has acquired Innovus Pharmaceuticals (posted on Sep 12, 2019).
Elanco has announced the acquisition of Bayer Animal Health (posted on Aug 20, 2019).

Most searched biographies at Boehringer Ingelheim

• Hubertus von Baumbach, Chairman of the Management Board
• Allan Hillgrove, Member of the Management Board, Human Pharma Busi...
• Andreas Neumann, Member of the Management Board, Human Resources

Click on an executive to view his biography >

Other contacts in the Pharmaceuticals industry

• Thomas Wozniewski - Senior Vice President, Global Senior Vice President, Global Manufacturing Officer at Takeda Pharmaceutical
• Claudio Bergamo dos Santos - Chief Executive Officer at Hypermarcas
• Des Walsh - Executive Vice Chairman of the Board at Herbalife Nutrition

Learn more about the Pharmaceuticals industry >

Latest news about Boehringer Ingelheim

Boehringer Ingelheim is committed to joining forces in the global fight against rabies | boehringer-ingelheim.com
New vaccine against Bovine Respiratory Disease | boehringer-ingelheim.com
NSCLC treatment sequencing survey | Press
Lume Meso Phase III Results | Press
Boehringer Ingelheim acquires ViraTherapeutics shares | Press

Boehringer Ingelheim on Wikipedia, Google News & Yahoo Finance

Boehringer Ingelheim on LinkedIn, Twitter & YouTube

Boehringer Ingelheim has 18 subsidiaries including Boehringer Ingelheim Animal Health, Boehringer Ingelheim Animal Health USA and Boehringer Ingelheim Belgium. Boehringer Ingelheim has 1,905 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Novartis (Switzerland).

Contact by email its executives including Michael Schmelmer

Call Boehringer Ingelheim at +49....

View the org chart

Register to receive your alert

Report an error